Hong is a Research Analyst at Vestal Point, primarily covering pre-commercial stage therapeutics. Before Vestal Point, Hong was a Senior Analyst at Ally Bridge Group from 2018 to 2023 focusing on biotechnology stocks.

Prior to Ally Bridge Group, he worked at RBC Capital Market (2016-2017). Before joining RBC, he worked at Ra Pharmaceuticals as a lead chemist (2012-2015). Hong graduated from Boston College with a Ph.D. in Chemistry.